Atherothrombotic burden and medium-term prognosis in patients with acute ischemic stroke: Findings of the SIRIO study

Claudio Cimminiello, Augusto Zaninelli, Antonio Carolei, Simona Sacco, Danilo Toni, Gianfranco Gensini

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Short-and medium-term mortality after acute stroke is related to the severity of the index event and the patient's age. However, recent studies have reassessed the prognostic value of the systemic atherothrombotic burden in these patients, not only in the long term. This post hoc analysis of the findings of the SIRIO trial (Stroke in Italy and Related Impact on Outcome) examined the prognostic impact of systemic atherothrombosis. Methods: SIRIO was a multicenter observational study enrolling patients during the acute phase of stroke of both ischemic and hemorrhagic origin. The present analysis, however, only covered patients with ischemic stroke. At baseline, the main personal and clinical details were recorded and patients were classified as having either polyvascular disease or single arterial disease on the basis of whether they had symptomatic atherothrombotic disease in other sites besides the cerebrovascular location. For all patients we calculated the Essen Stroke Risk Score (ESRS), dividing them into groups with scores of less than 3 or 3 and more. We recorded total mortality and nonfatal vascular events 12 months after enrolment. Multivariate logistic regression analysis was used to select predictors of medium-term mortality and nonfatal cardiovascular events. There were 2,561 patients with ischemic stroke, 823 of them classified as having polyvascular disease; 940 (out of 2,485) had an ESRS of less than 3 and 1,545 had a score of 3 or more. Results: The combined endpoint 'death (all causes) and nonfatal cardiovascular events within 12 months of hospital discharge' was significantly dependent on the following factors: ESRS, Rankin scale and National Institutes of Health Stroke Scale scores, and polyvascular disease. Polyvascular disease status significantly affected mortality and nonfatal cardio-and cerebrovascular events after discharge (OR = 1.44, 95% CI = 1.10-1.88). Age was also confirmed as a significant predictor of the combined endpoint. Conclusions: Besides age and the clinical severity of the index event, symptomatic involvement of several vascular districts was also an important predictor of mortality and nonfatal cardiovascular events in the medium term in patients with ischemic stroke.

Original languageEnglish
Pages (from-to)341-347
Number of pages7
JournalCerebrovascular Diseases
Volume33
Issue number4
DOIs
Publication statusPublished - Apr 2012

Fingerprint

Stroke
Mortality
Blood Vessels
National Institutes of Health (U.S.)
Italy
Multicenter Studies
Observational Studies
Cause of Death
Logistic Models
Regression Analysis

Keywords

  • Acute ischemic stroke
  • Atherothrombotic burden
  • SIRIO trial

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Atherothrombotic burden and medium-term prognosis in patients with acute ischemic stroke : Findings of the SIRIO study. / Cimminiello, Claudio; Zaninelli, Augusto; Carolei, Antonio; Sacco, Simona; Toni, Danilo; Gensini, Gianfranco.

In: Cerebrovascular Diseases, Vol. 33, No. 4, 04.2012, p. 341-347.

Research output: Contribution to journalArticle

Cimminiello, Claudio ; Zaninelli, Augusto ; Carolei, Antonio ; Sacco, Simona ; Toni, Danilo ; Gensini, Gianfranco. / Atherothrombotic burden and medium-term prognosis in patients with acute ischemic stroke : Findings of the SIRIO study. In: Cerebrovascular Diseases. 2012 ; Vol. 33, No. 4. pp. 341-347.
@article{523f36bae93b4f439f8f9e09b85f9ad3,
title = "Atherothrombotic burden and medium-term prognosis in patients with acute ischemic stroke: Findings of the SIRIO study",
abstract = "Background: Short-and medium-term mortality after acute stroke is related to the severity of the index event and the patient's age. However, recent studies have reassessed the prognostic value of the systemic atherothrombotic burden in these patients, not only in the long term. This post hoc analysis of the findings of the SIRIO trial (Stroke in Italy and Related Impact on Outcome) examined the prognostic impact of systemic atherothrombosis. Methods: SIRIO was a multicenter observational study enrolling patients during the acute phase of stroke of both ischemic and hemorrhagic origin. The present analysis, however, only covered patients with ischemic stroke. At baseline, the main personal and clinical details were recorded and patients were classified as having either polyvascular disease or single arterial disease on the basis of whether they had symptomatic atherothrombotic disease in other sites besides the cerebrovascular location. For all patients we calculated the Essen Stroke Risk Score (ESRS), dividing them into groups with scores of less than 3 or 3 and more. We recorded total mortality and nonfatal vascular events 12 months after enrolment. Multivariate logistic regression analysis was used to select predictors of medium-term mortality and nonfatal cardiovascular events. There were 2,561 patients with ischemic stroke, 823 of them classified as having polyvascular disease; 940 (out of 2,485) had an ESRS of less than 3 and 1,545 had a score of 3 or more. Results: The combined endpoint 'death (all causes) and nonfatal cardiovascular events within 12 months of hospital discharge' was significantly dependent on the following factors: ESRS, Rankin scale and National Institutes of Health Stroke Scale scores, and polyvascular disease. Polyvascular disease status significantly affected mortality and nonfatal cardio-and cerebrovascular events after discharge (OR = 1.44, 95{\%} CI = 1.10-1.88). Age was also confirmed as a significant predictor of the combined endpoint. Conclusions: Besides age and the clinical severity of the index event, symptomatic involvement of several vascular districts was also an important predictor of mortality and nonfatal cardiovascular events in the medium term in patients with ischemic stroke.",
keywords = "Acute ischemic stroke, Atherothrombotic burden, SIRIO trial",
author = "Claudio Cimminiello and Augusto Zaninelli and Antonio Carolei and Simona Sacco and Danilo Toni and Gianfranco Gensini",
year = "2012",
month = "4",
doi = "10.1159/000335833",
language = "English",
volume = "33",
pages = "341--347",
journal = "Cerebrovascular Diseases",
issn = "1015-9770",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Atherothrombotic burden and medium-term prognosis in patients with acute ischemic stroke

T2 - Findings of the SIRIO study

AU - Cimminiello, Claudio

AU - Zaninelli, Augusto

AU - Carolei, Antonio

AU - Sacco, Simona

AU - Toni, Danilo

AU - Gensini, Gianfranco

PY - 2012/4

Y1 - 2012/4

N2 - Background: Short-and medium-term mortality after acute stroke is related to the severity of the index event and the patient's age. However, recent studies have reassessed the prognostic value of the systemic atherothrombotic burden in these patients, not only in the long term. This post hoc analysis of the findings of the SIRIO trial (Stroke in Italy and Related Impact on Outcome) examined the prognostic impact of systemic atherothrombosis. Methods: SIRIO was a multicenter observational study enrolling patients during the acute phase of stroke of both ischemic and hemorrhagic origin. The present analysis, however, only covered patients with ischemic stroke. At baseline, the main personal and clinical details were recorded and patients were classified as having either polyvascular disease or single arterial disease on the basis of whether they had symptomatic atherothrombotic disease in other sites besides the cerebrovascular location. For all patients we calculated the Essen Stroke Risk Score (ESRS), dividing them into groups with scores of less than 3 or 3 and more. We recorded total mortality and nonfatal vascular events 12 months after enrolment. Multivariate logistic regression analysis was used to select predictors of medium-term mortality and nonfatal cardiovascular events. There were 2,561 patients with ischemic stroke, 823 of them classified as having polyvascular disease; 940 (out of 2,485) had an ESRS of less than 3 and 1,545 had a score of 3 or more. Results: The combined endpoint 'death (all causes) and nonfatal cardiovascular events within 12 months of hospital discharge' was significantly dependent on the following factors: ESRS, Rankin scale and National Institutes of Health Stroke Scale scores, and polyvascular disease. Polyvascular disease status significantly affected mortality and nonfatal cardio-and cerebrovascular events after discharge (OR = 1.44, 95% CI = 1.10-1.88). Age was also confirmed as a significant predictor of the combined endpoint. Conclusions: Besides age and the clinical severity of the index event, symptomatic involvement of several vascular districts was also an important predictor of mortality and nonfatal cardiovascular events in the medium term in patients with ischemic stroke.

AB - Background: Short-and medium-term mortality after acute stroke is related to the severity of the index event and the patient's age. However, recent studies have reassessed the prognostic value of the systemic atherothrombotic burden in these patients, not only in the long term. This post hoc analysis of the findings of the SIRIO trial (Stroke in Italy and Related Impact on Outcome) examined the prognostic impact of systemic atherothrombosis. Methods: SIRIO was a multicenter observational study enrolling patients during the acute phase of stroke of both ischemic and hemorrhagic origin. The present analysis, however, only covered patients with ischemic stroke. At baseline, the main personal and clinical details were recorded and patients were classified as having either polyvascular disease or single arterial disease on the basis of whether they had symptomatic atherothrombotic disease in other sites besides the cerebrovascular location. For all patients we calculated the Essen Stroke Risk Score (ESRS), dividing them into groups with scores of less than 3 or 3 and more. We recorded total mortality and nonfatal vascular events 12 months after enrolment. Multivariate logistic regression analysis was used to select predictors of medium-term mortality and nonfatal cardiovascular events. There were 2,561 patients with ischemic stroke, 823 of them classified as having polyvascular disease; 940 (out of 2,485) had an ESRS of less than 3 and 1,545 had a score of 3 or more. Results: The combined endpoint 'death (all causes) and nonfatal cardiovascular events within 12 months of hospital discharge' was significantly dependent on the following factors: ESRS, Rankin scale and National Institutes of Health Stroke Scale scores, and polyvascular disease. Polyvascular disease status significantly affected mortality and nonfatal cardio-and cerebrovascular events after discharge (OR = 1.44, 95% CI = 1.10-1.88). Age was also confirmed as a significant predictor of the combined endpoint. Conclusions: Besides age and the clinical severity of the index event, symptomatic involvement of several vascular districts was also an important predictor of mortality and nonfatal cardiovascular events in the medium term in patients with ischemic stroke.

KW - Acute ischemic stroke

KW - Atherothrombotic burden

KW - SIRIO trial

UR - http://www.scopus.com/inward/record.url?scp=84857467962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857467962&partnerID=8YFLogxK

U2 - 10.1159/000335833

DO - 10.1159/000335833

M3 - Article

C2 - 22378350

AN - SCOPUS:84857467962

VL - 33

SP - 341

EP - 347

JO - Cerebrovascular Diseases

JF - Cerebrovascular Diseases

SN - 1015-9770

IS - 4

ER -